[1] |
Xie J, Chen N. Primary glomerulonephritis in mainland China: an overview [J]. Contrib Nephrol, 2013, 181: 1-11.
|
[2] |
Xu L, Yang HC, Hao CM, et al. Podocyte number predicts progression of proteinuria in IgA nephropathy [J]. Mod Pathol, 2010, 23(9): 1241-1250.
|
[3] |
Nielsen JS, Mcnagny KM. The role of podocalyxin in health and disease [J]. J Am Soc Nephrol, 2009, 20(8): 1669-1676.
|
[4] |
Hara M, Yanagihara T, Hirayama Y, et al. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli [J]. Hum pathol, 2010, 41(9): 1265-1275.
|
[5] |
Asao R, Asanuma K, Kodama F, et al. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy [J]. Clin J Am Soc Nephrol, 2012, 7(9): 1385-1393.
|
[6] |
Asanuma K, Campbell KN, Kim K, et al. Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes [J]. Proc Natl Acad Sci USA, 2007, 104(24): 10134-10139.
|
[7] |
Kodama F, Asanuma K, Takagi M, et al. Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy [J]. Nephrol Dial Transplant, 2013, 28(7): 1762-1772.
|
[8] |
Coppo R, Amore A, Peruzzi L, et al. Innate immunity and IgA nephropathy [J]. J Nephrol, 2010, 23(6): 626-632.
|
[9] |
Liu LL, Jiang Y, Wang LN, et al. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy [J]. Clin Exp Immunol, 2012, 169(2): 148-55.
|
[10] |
Onda K, Ohsawa I, Ohi H, et al. Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function [J]. BMC Nephrol, 2011, 12: 64.
|
[11] |
Zhang JJ, Jiang L, Liu G, et al. Levels of urinary complement factor H in patients with IgA nephropathy are closely associated with disease activity [J]. Scand J Immunol, 2009, 69(5): 457-464.
|
[12] |
Liu L, Zhang Y, Duan X, et al. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy [J]. J Clin Immunol, 2014, 34(2): 224-232.
|
[13] |
Miyake-Ogawa C, Miyazaki M, Abe K, et al. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy [J]. Am J Nephrol, 2005, 25(1): 1-12.
|
[14] |
Nishiyama A, Konishi Y, Ohashi N, et al. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy [J]. Nephrol Dial Transplant, 2011, 26(1): 170-177.
|
[15] |
Kim YG, Song SB, Lee SH, et al. Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy [J]. Clin Exp Nephrol, 2011, 15(5): 720-726.
|
[16] |
Rocchetti MT1, Tamma G, Lasorsa D, et al. Altered urinary excretion of aquaporin 2 in IgA nephropathy [J]. Eur J Endocrinol, 2011, 165(4): 657-664.
|
[17] |
Lu X, Li M, Zhou L, et al. Urinary serum- and glucocorticoid-inducible kinase SGK1 reflects renal injury in patients with immunoglobulin A nephropathy [J]. Nephrology (Carlton), 2014, 19(6): 307-317.
|
[18] |
Stangou M, Papagianni A, Bantis C, et al. Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine [J]. Clin Nephrol, 2013, 80(3): 203-210.
|
[19] |
Ranieri E, Gesualdo L, Petrarulo F, et al. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy [J]. Kidney Int, 1996, 50(6): 1990-2001.
|
[20] |
Torres DD, Rossini M, Manno C, et al. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy [J]. Kidney Int, 2008, 73(3): 327-333.
|
[21] |
Stangou M, Alexopoulos E, Papagianni A, et al. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy [J]. Nephrology (Carlton), 2009, 14(6): 613-620.
|
[22] |
Han WK, Bailly V, Abichandani R, et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury [J]. Kidney Int, 2002, 62(1): 237-244.
|
[23] |
van Timmeren MM, van den Heuvel MC, Bailly V, et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease [J]. J Pathol, 2007, 212(2): 209-217.
|
[24] |
Vaidya VS, Waikar SS, Ferguson MA, et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans [J]. Clin Transl Sci, 2008, 1(3): 200-208.
|
[25] |
Xu PC, Zhang JJ, Chen M, et al. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity [J]. Nephrol Dial Transplant, 2011, 26(10): 3229-3236.
|
[26] |
Peters HP, Waanders F, Meijer E, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy [J]. Nephrol Dial Transplant, 2011, 26(11): 3581-3588.
|
[27] |
Wu J, Wang N, Wang J, et al. Identification of a uromodulin fragment for diagnosis of IgA nephropathy [J]. Rapid Commun Mass Spectrom, 2010, 24(14): 1971-1978.
|
[28] |
Obara T1, Mizoguchi S, Shimozuru Y, et al. The complex of immunoglobulin A and uromodulin as a diagnostic marker for immunoglobulin A nephropathy [J]. Clin Exp Nephrol, 2012, 16(5): 713-721.
|
[29] |
Rocchetti MT, Papale M, d′Apollo AM, et al. Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy [J]. Clin J Am Soc Nephrol, 2013, 8(7): 1115-1125.
|
[30] |
Surin B, Sachon E, Rougier JP, et al. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy [J]. Proteomics, 2013, 13(1): 142-152.
|
[31] |
Wang G, Kwan BC, Lai FM, et al. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy [J]. Dis Markers, 2010, 28(2): 79-86.
|
[32] |
Wang G, Kwan BC, Lai FM, et al. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy [J]. Dis Markers, 2011, 30(4): 171-179.
|
[33] |
Szeto CC, Ching-Ha KB, Ka-Bik L, et al. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases [J]. Dis Markers, 2012, 33(3): 137-144.
|
[34] |
Gonzales PA, Pisitkun T, Hoffert JD, et al. Large-scale proteomics and phosphoproteomics of urinary exosomes [J]. J Am Soc Nephrol, 2009, 20(2): 363-379.
|